Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1)

Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1)

Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1) structure

Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1) 

structure
  • CAS No:

    3778-76-5

  • Formula:

    C11H12N4O2.ClH

  • Chemical Name:

    Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1)

  • Synonyms:

    Hydrazinecarboxylic acid,2-(1-phthalazinyl)-,ethyl ester,hydrochloride (1:1);Carbazic acid,3-(1-phthalazinyl)-,ethyl ester,monohydrochloride;Hydrazinecarboxylic acid,2-(1-phthalazinyl)-,ethyl ester,monohydrochloride;Binazine;Binazin;N-Carbethoxy-N′-phthalazinohydrazide hydrochloride;2-Carbethoxy-1-(1-phthalazinyl)hydrazine hydrochloride;N1-Carboethoxy-N1-hydrazinophthalazine;Apirachol;Apiracohl;Ecarazine hydrochloride;Ecarazine;Todralazine hydrochloride;N-Carbethoxy-N′-(1-phthalazino)hydrazine hydrochloride;Apredor;Illcut;CEPH;Atapren;Propat;Apride;BT 621

  • Categories:

    Analytical Chemistry  >  Standard

Description

Todralazine hydrochloride (Ecarazine hydrochloride) is an anti-hypertensive agent, acts as a β2AR blocker, with antioxidant and free radical scavenging activity[1].


An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.

Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1) Basic Attributes

268.7

268.07300

C59540FEXP

757868

DTXSID4044664

2933990090

Characteristics

76.14000

2.96870

1.328g/cm3

LD50 i.p. in mice: 500 mg/kg (Parravincini)

150 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

3

20/21/22

36

FE2778600

Xn

P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, P501

H302

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

Apirachol

Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, hydrochloride (1:1) Use and Manufacturing

Antihypertensor

Computed Properties

Molecular Weight:268.70
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:4
Exact Mass:268.0727034
Monoisotopic Mass:268.0727034
Topological Polar Surface Area:76.1
Heavy Atom Count:18
Complexity:262
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.